|
1
|
Lagunas-Rangel FA: Circular RNAs and their
participation in stemness of cancer. Med Oncol. 37:422020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang H, Cui G, Yu B, Sun M and Yang H:
Cancer stem cell niche in colorectal cancer and targeted therapies.
Curr Pharm Des. 26:1979–1993. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sureshbabu SK, Chaukar D and Chiplunkar
SV: Hypoxia regulates the differentiation and anti-tumor effector
functions of γδT cells in oral cancer. Clin Exp Immunol. 201:40–57.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang C, Samanta D, Lu H, Bullen JW, Zhang
H, Chen I, He X and Semenza GL: Hypoxia induces the breast cancer
stem cell phenotype by HIF-dependent and ALKBH5-mediated
m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA.
113:E2047–E2056. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu QH, Xiao Y, Li XQ, Fan L, Zhou CC,
Cheng L, Jiang ZD and Wang GH: Resveratrol Counteracts
Hypoxia-Induced Gastric Cancer Invasion and EMT through Hedgehog
Pathway Suppression. Anticancer Agents Med Chem. 20:1105–1114.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ajduković J: HIF-1 - a big chapter in the
cancer tale. Exp Oncol. 38:9–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schito L and Semenza GL: Hypoxia-inducible
factors: Master regulators of cancer progression. Trends Cancer.
2:758–770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Y, Wang L, Ding W, Wang D, Wang X, Luo
Q and Zhu L: Ammonia mediates mitochondrial uncoupling and promotes
glycolysis via HIF-1 activation in human breast cancer MDA-MB-231
cells. Biochem Biophys Res Commun. 519:153–159. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Azimi I: The interplay between HIF-1 and
calcium signalling in cancer. Int J Biochem Cell Biol. 97:73–77.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong M, Shi H, Wang N, Tan HY, Wang Q and
Feng Y: Dual effects of Chinese herbal medicines on angiogenesis in
cancer and ischemic stroke treatments: Role of HIF-1 network. Front
Pharmacol. 10:6962019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Albadari N, Deng S and Li W: The
transcriptional factors HIF-1 and HIF-2 and their novel inhibitors
in cancer therapy. Expert Opin Drug Discov. 14:667–682. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garner KEL, Hull NJ, Sims AH, Lamb R and
Clarke RB: The milk protein alpha-casein suppresses triple negative
breast cancer stem cell activity via STAT and HIF-1alpha signalling
pathways in breast cancer cells and fibroblasts. J Mammary Gland
Biol Neoplasia. 24:245–256. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan ST, Patel PR, Ransom TR, Henrich CJ,
McKee TC, Goey AK, Cook KM, Figg WD, McMahon JB, Schnermann MJ, et
al: Structural elucidation and synthesis of eudistidine A: An
unusual polycyclic marine alkaloid that blocks interaction of the
protein binding domains of p300 and HIF-1α. J Am Chem Soc.
137:5569–5575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Freedman SJ, Sun ZY, Kung AL, France DS,
Wagner G and Eck MJ: Structural basis for negative regulation of
hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol.
10:504–512. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kasper LH, Boussouar F, Boyd K, Xu W,
Biesen M, Rehg J, Baudino TA, Cleveland JL and Brindle PK: Two
transactivation mechanisms cooperate for the bulk of
HIF-1-responsive gene expression. EMBO J. 24:3846–3858. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Henchey LK, Kushal S, Dubey R, Chapman RN,
Olenyuk BZ and Arora PS: Inhibition of hypoxia inducible factor
1-transcription coactivator interaction by a hydrogen bond
surrogate alpha-helix. J Am Chem Soc. 132:941–943. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai X, Huang Y, Zhang X, Wang S, Zou Z,
Wang G, Wang Y and Zhang Z: Cloning, characterization, hypoxia and
heat shock response of hypoxia inducible factor-1 (HIF-1) from the
small abalone Haliotis diversicolor. Gene. 534:256–264. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu CJ, Sataur A, Wang L, Chen H and Simon
MC: The N-terminal transactivation domain confers target gene
specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.
Mol Biol Cell. 18:4528–4542. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soñanez-Organis JG, Peregrino-Uriarte AB,
Gómez-Jiménez S, López-Zavala A, Forman HJ and Yepiz-Plascencia G:
Molecular characterization of hypoxia inducible factor-1 (HIF-1)
from the white shrimp Litopenaeus vannamei and
tissue-specific expression under hypoxia. Comp Biochem Physiol C
Toxicol Pharmacol. 150:395–405. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soni S and Padwad YS: HIF-1 in cancer
therapy: Two decade long story of a transcription factor. Acta
Oncol. 56:503–515. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ju UI, Park JW, Park HS, Kim SJ and Chun
YS: FBXO11 represses cellular response to hypoxia by destabilizing
hypoxia-inducible factor-1α mRNA. Biochem Biophys Res Commun.
464:1008–1015. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mandl M and Depping R: Hypoxia-inducible
aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): Is
it a rare exception? Mol Med. 20:215–220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qiu Y, Shan W, Yang Y, Jin M, Dai Y, Yang
H, Jiao R, Xia Y, Liu Q, Ju L, et al: Reversal of sorafenib
resistance in hepatocellular carcinoma: Epigenetically regulated
disruption of 14-3-3η/hypoxia-inducible factor-1α. Cell Death
Discov. 5:1202019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karagiota A, Kourti M, Simos G and Mylonis
I: HIF-1α-derived cell-penetrating peptides inhibit ERK-dependent
activation of HIF-1 and trigger apoptosis of cancer cells under
hypoxia. Cell Mol Life Sci. 76:809–825. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh A, Gupta S and Sachan M: Epigenetic
biomarkers in the management of ovarian cancer: Current
prospectives. Front Cell Dev Biol. 7:1822019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Urbano A, Smith J, Weeks RJ and Chatterjee
A: Gene-specific targeting of DNA methylation in the mammalian
genome. Cancers. 11:15152019. View Article : Google Scholar
|
|
28
|
Liu Q, Liu L, Zhao Y, Zhang J, Wang D,
Chen J, He Y, Wu J, Zhang Z and Liu Z: Hypoxia induces genomic DNA
demethylation through the activation of HIF-1α and transcriptional
upregulation of MAT2A in hepatoma cells. Mol Cancer Ther.
10:1113–1123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han ZJ, Feng YH, Gu BH, Li YM and Chen H:
The post-translational modification, SUMOylation, and cancer
(Review). Int J Oncol. 52:1081–1094. 2018.PubMed/NCBI
|
|
30
|
Bao L, Chen Y, Lai HT, Wu SY, Wang JE,
Hatanpaa KJ, Raisanen JM, Fontenot M, Lega B, Chiang CM, et al:
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP
inhibits HIF-1 transcriptional activity and cell migration. Nucleic
Acids Res. 46:6576–6591. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cui CP, Wong CC, Kai AK, Ho DW, Lau EY,
Tsui YM, Chan LK, Cheung TT, Chok KS, Chan AC, et al: SENP1
promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation
and SENP1/HIF-1α positive feedback loop. Gut. 66:2149–2159. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Liang X, Liang H and Wang B:
SENP1/HIF-1α feedback loop modulates hypoxia-induced cell
proliferation, invasion, and EMT in human osteosarcoma cells. J
Cell Biochem. 119:1819–1826. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mylonis I, Kourti M, Samiotaki M,
Panayotou G and Simos G: Mortalin-mediated and ERK-controlled
targeting of HIF-1α to mitochondria confers resistance to apoptosis
under hypoxia. J Cell Sci. 130:466–479. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bullen JW, Tchernyshyov I, Holewinski RJ,
DeVine L, Wu F, Venkatraman V, Kass DL, Cole RN, Van Eyk J and
Semenza GL: Protein kinase A-dependent phosphorylation stimulates
the transcriptional activity of hypoxia-inducible factor 1. Sci
Signal. 9:ra562016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gong H, Gao S, Yu C, Li M, Liu P, Zhang G,
Song J and Zheng J: Effect and mechanism of YB-1 knockdown on
glioma cell growth, migration, and apoptosis. Acta Biochim Biophys
Sin (Shanghai). 52:168–179. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
El-Naggar AM, Veinotte CJ, Cheng H,
Grunewald TG, Negri GL, Somasekharan SP, Corkery DP, Tirode F,
Mathers J, Khan D, et al: Translational activation of HIF1α by YB-1
promotes sarcoma metastasis. Cancer Cell. 27:682–697. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu AM, Batra N, Tu MJ and Sweeney C: Novel
approaches for efficient in vivo fermentation production of
noncoding RNAs. Appl Microbiol Biotechnol. 104:1927–1937. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Panir K, Schjenken JE, Robertson SA and
Hull ML: Non-coding RNAs in endometriosis: A narrative review. Hum
Reprod Update. 24:497–515. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu C, Xing H, Guo C, Yang Z and Wang Y
and Wang Y: MiR-124 reversed the doxorubicin resistance of breast
cancer stem cells through STAT3/HIF-1 signaling pathways. Cell
Cycle. 18:2215–2227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bartoszewski R, Serocki M,
Janaszak-Jasiecka A, Bartoszewska S, Kochan-Jamrozy K, Piotrowski
A, Króliczewski J and Collawn JF: miR-200b downregulates Krüppel
Like Factor 2 (KLF2) during acute hypoxia in human endothelial
cells. Eur J Cell Biol. 96:758–766. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Byun Y, Choi YC, Jeong Y, Lee G, Yoon S,
Jeong Y, Yoon J and Baek K: MiR-200c downregulates HIF-1α and
inhibits migration of lung cancer cells. Cell Mol Biol Lett.
24:282019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen X, Wu L, Li D, Xu Y, Zhang L, Niu K,
Kong R, Gu J, Xu Z, Chen Z, et al: Radiosensitizing effects of
miR-18a-5p on lung cancer stem-like cells via downregulating both
ATM and HIF-1α. Cancer Med. 7:3834–3847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Krutilina R, Sun W, Sethuraman A, Brown M,
Seagroves TN, Pfeffer LM, Ignatova T and Fan M: MicroRNA-18a
inhibits hypoxia-inducible factor 1α activity and lung metastasis
in basal breast cancers. Breast Cancer Res. 16:R782014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mathieu J, Zhang Z, Zhou W, Wang AJ,
Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, et al:
HIF induces human embryonic stem cell markers in cancer cells.
Cancer Res. 71:4640–4652. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ho AS, Huang X, Cao H, Christman-Skieller
C, Bennewith K, Le QT and Koong AC: Circulating miR-210 as a novel
hypoxia marker in pancreatic cancer. Transl Oncol. 3:109–113. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sabry D, El-Deek SE, Maher M, El-Baz MA,
El-Bader HM, Amer E, Hassan EA, Fathy W and El-Deek HE: Role of
miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in
colorectal carcinoma: Impact of HIF-1α-VEGF signaling pathway. Mol
Cell Biochem. 454:177–189. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang W, Wei J, Guo T, Shen Y and Liu F:
Knockdown of miR-210 decreases hypoxic glioma stem cells stemness
and radioresistance. Exp Cell Res. 326:22–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N,
Zhu Z, Mo Z, Wu C and Chen X: MiR-21 regulates
epithelial-mesenchymal transition phenotype and hypoxia-inducible
factor-1α expression in third-sphere forming breast cancer stem
cell-like cells. Cancer Sci. 103:1058–1064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hermansen SK, Nielsen BS, Aaberg-Jessen C
and Kristensen BW: miR-21 is linked to glioma angiogenesis: A
co-localization study. J Histochem Cytochem. 64:138–148. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guo Y, Xiao Z, Yang L, Gao Y, Zhu Q, Hu L,
Huang D and Xu Q: Hypoxia inducible factors in hepatocellular
carcinoma (Review). Oncol Rep. 43:3–15. 2020.PubMed/NCBI
|
|
51
|
Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei
Y, Tang K, Sun Y, Zhang W, Li S, et al: HIF-1α-regulated miR-1275
maintains stem cell-like phenotypes and promotes the progression of
LUAD by simultaneously activating Wnt/β-catenin and Notch
signaling. Theranostics. 10:2553–2570. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ge X, Liu X, Lin F, Li P, Liu K, Geng R,
Dai C, Lin Y, Tang W, Wu Z, et al: MicroRNA-421 regulated by HIF-1α
promotes metastasis, inhibits apoptosis, and induces cisplatin
resistance by targeting E-cadherin and caspase-3 in gastric cancer.
Oncotarget. 7:24466–24482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Chen J, Zhou X, Xiao Q, Wang T, Shao G, Li
Y and Zhang Z: MiR-107 suppresses cell proliferation and tube
formation of Ewing sarcoma cells partly by targeting HIF-1β. Hum
Cell. 31:42–49. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang Z, Han Y, Cheng K, Zhang G and Wang
X: miR-99a directly targets the mTOR signalling pathway in breast
cancer side population cells. Cell Prolif. 47:587–595. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY,
Wu KJ, Chiou SH, Lin SC and Chang KW: miR-31 ablates expression of
the HIF regulatory factor FIH to activate the HIF pathway in head
and neck carcinoma. Cancer Res. 70:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hung PS, Tu HF, Kao SY, Yang CC, Liu CJ,
Huang TY, Chang KW and Lin SC: miR-31 is upregulated in oral
premalignant epithelium and contributes to the immortalization of
normal oral keratinocytes. Carcinogenesis. 35:1162–1171. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen T, Yao LQ, Shi Q, Ren Z, Ye LC, Xu
JM, Zhou PH and Zhong YS: MicroRNA-31 contributes to colorectal
cancer development by targeting factor inhibiting HIF-1α (FIH-1).
Cancer Biol Ther. 15:516–523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
He J, Jin S, Zhang W, Wu D, Li J, Xu J and
Gao W: Long non-coding RNA LOC554202 promotes acquired gefitinib
resistance in non-small cell lung cancer through upregulating
miR-31 expression. J Cancer. 10:6003–6013. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhu B, Cao X, Zhang W, Pan G, Yi Q, Zhong
W and Yan D: MicroRNA-31-5p enhances the Warburg effect via
targeting FIH. FASEB J. 33:545–556. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kao SY, Tsai MM, Wu CH, Chen JJ, Tseng SH,
Lin SC and Chang KW: Co-targeting of multiple microRNAs on
factor-Inhibiting hypoxia-Inducible factor gene for the
pathogenesis of head and neck carcinomas. Head Neck. 38:522–528.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shih JW and Kung HJ: Long non-coding RNA
and tumor hypoxia: New players ushered toward an old arena. J
Biomed Sci. 24:532017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Dong J, Xu J, Wang X and Jin B: Influence
of the interaction between long noncoding RNAs and hypoxia on
tumorigenesis. Tumour Biol. 37:1379–1385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ge H, Yan Y, Wu D, Huang Y and Tian F:
Potential role of LINC00996 in colorectal cancer: A study based on
data mining and bioinformatics. OncoTargets Ther. 11:4845–4855.
2018. View Article : Google Scholar
|
|
64
|
Yang F, Zhang H, Mei Y and Wu M:
Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the
Warburg effect. Mol Cell. 53:88–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Shen Y, Liu Y, Sun T and Yang W:
LincRNA-p21 knockdown enhances radiosensitivity of hypoxic tumor
cells by reducing autophagy through HIF-1/Akt/mTOR/P70S6K pathway.
Exp Cell Res. 358:188–198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Shih JW, Chiang WF, Wu AT, Wu MH, Wang LY,
Yu YL, Hung YW, Wang WC, Chu CY, Hung CL, et al: Long noncoding RNA
LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer
progression. Nat Commun. 8:158742017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang J, Jin HY, Wu Y, Zheng ZC, Guo S,
Wang Y, Yang D, Meng XY, Xu X and Zhao Y: Hypoxia-induced LncRNA
PCGEM1 promotes invasion and metastasis of gastric cancer through
regulating SNAI1. Clin Transl Oncol. 21:1142–1151. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang W, Wang J, Chai R, Zhong G, Zhang C,
Cao W, Yan L, Zhang X and Xu Z: Hypoxia-regulated lncRNA CRPAT4
promotes cell migration via regulating AVL9 in clear cell renal
cell carcinomas. OncoTargets Ther. 11:4537–4545. 2018. View Article : Google Scholar
|
|
69
|
Yang W, Sun T, Cao J and Fan S:
Hypoxia-inducible factor-1α downregulation by small interfering RNA
inhibits proliferation, induces apoptosis, and enhances
radiosensitivity in chemical hypoxic human hepatoma SMMC-7721
cells. Cancer Biother Radiopharm. 26:565–571. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Staab A, Fleischer M, Loeffler J, Said HM,
Katzer A, Plathow C, Einsele H, Flentje M and Vordermark D: Small
interfering RNA targeting HIF-1alpha reduces hypoxia-dependent
transcription and radiosensitizes hypoxic HT 1080 human
fibrosarcoma cells in vitro. Strahlenther Onkol. 187:252–259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Yu X, Hu L, Li S, Shen J, Wang D, Xu R and
Yang H: Long non-coding RNA Taurine upregulated gene 1 promotes
osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.
Cell Death Dis. 10:2802019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Augoff K, McCue B, Plow EF and
Sossey-Alaoui K: miR-31 and its host gene lncRNA LOC554202 are
regulated by promoter hypermethylation in triple-negative breast
cancer. Mol Cancer. 11:52012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sun Y, Jia X, Wang M and Deng Y: Long
noncoding RNA MIR31HG abrogates the availability of tumor
suppressor microRNA-361 for the growth of osteosarcoma. Cancer
Manag Res. 11:8055–8064. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Liu Y, Zhu J, Ma X, Han S, Xiao D, Jia Y
and Wang Y: ceRNA network construction and comparison of gastric
cancer with or without Helicobacter pylori infection. J Cell
Physiol. 234:7128–7140. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sun J, Yan J, Yuan X, Yang R, Dan T, Wang
X, Kong G and Gao S: A computationally constructed ceRNA
interaction network based on a comparison of the SHEE and SHEEC
cell lines. Cell Mol Biol Lett. 21:212016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhang Q, Cheng Q, Xia M, Huang X, He X and
Liao J: Hypoxia-induced lncRNA-NEAT1 sustains the growth of
hepatocellular carcinoma via regulation of miR-199a-3p/UCK2. Front
Oncol. 10:9982020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
van Schaijik B, Davis PF, Wickremesekera
AC, Tan ST and Itinteang T: Subcellular localisation of the stem
cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: A review.
J Clin Pathol. 71:88–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang Z and Zöller M: Exosomes, metastases,
and the miracle of cancer stem cell markers. Cancer Metastasis Rev.
38:259–295. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lin YT and Wu KJ: Epigenetic regulation of
epithelial-mesenchymal transition: Focusing on hypoxia and TGF-β
signaling. J Biomed Sci. 27:392020. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Rankin EB, Nam JM and Giaccia AJ: Hypoxia:
Signaling the metastatic cascade. Trends Cancer. 2:295–304. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Hajizadeh F, Okoye I, Esmaily M, Ghasemi
Chaleshtari M, Masjedi A, Azizi G, Irandoust M, Ghalamfarsa G and
Jadidi-Niaragh F: Hypoxia inducible factors in the tumor
microenvironment as therapeutic targets of cancer stem cells. Life
Sci. 237:1169522019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhang H, Lu H, Xiang L, Bullen JW, Zhang
C, Samanta D, Gilkes DM, He J and Semenza GL: HIF-1 regulates CD47
expression in breast cancer cells to promote evasion of
phagocytosis and maintenance of cancer stem cells. Proc Natl Acad
Sci USA. 112:E6215–E6223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Thomas S, Harding MA, Smith SC, Overdevest
JB, Nitz MD, Frierson HF, Tomlins SA, Kristiansen G and Theodorescu
D: CD24 is an effector of HIF-1-driven primary tumor growth and
metastasis. Cancer Res. 72:5600–5612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ohnishi S, Maehara O, Nakagawa K, Kameya
A, Otaki K, Fujita H, Higashi R, Takagi K, Asaka M, Sakamoto N, et
al: hypoxia-inducible factors activate CD133 promoter through ETS
family transcription factors. PLoS One. 8:e662552013. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Hashimoto O, Shimizu K, Semba S, Chiba S,
Ku Y, Yokozaki H and Hori Y: Hypoxia induces tumor aggressiveness
and the expansion of CD133-positive cells in a hypoxia-inducible
factor-1alpha-dependent manner in pancreatic cancer cells.
Pathobiology. 78:181–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chiu DK, Zhang MS, Tse AP and Wong CC:
Assessment of stabilization and activity of the HIFs important for
hypoxia-induced signalling in cancer cells. Methods Mol Biol.
1928:77–99. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Soeda A, Park M, Lee D, Mintz A,
Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T,
Kassam AB, et al: Hypoxia promotes expansion of the CD133-positive
glioma stem cells through activation of HIF-1alpha. Oncogene.
28:3949–3959. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Hashimoto K, Aoyagi K, Isobe T, Kouhuji K
and Shirouzu K: Expression of CD133 in the cytoplasm is associated
with cancer progression and poor prognosis in gastric cancer.
Gastric Cancer. 17:97–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Maeda K, Ding Q, Yoshimitsu M, Kuwahata T,
Miyazaki Y, Tsukasa K, Hayashi T, Shinchi H, Natsugoe S and Takao
S: CD133 modulate HIF-1alpha expression under hypoxia in EMT
phenotype pancreatic cancer stem-like cells. Int J Mol Sci.
17:10252016. View Article : Google Scholar
|
|
90
|
Matsumoto K, Arao T, Tanaka K, Kaneda H,
Kudo K, Fujita Y, Tamura D, Aomatsu K, Tamura T, Yamada Y, et al:
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133
expression in cancer cells. Cancer Res. 69:7160–7164. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Li SW, Wu XL, Dong CL, Xie XY, Wu JF and
Zhang X: The differential expression of OCT4 isoforms in cervical
carcinoma. PLoS One. 10:e01180332015. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ciccone V, Terzuoli E, Donnini S,
Giachetti A, Morbidelli L and Ziche M: Stemness marker ALDH1A1
promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF
signalling in MCF-7 breast cancer cells. J Exp Clin Cancer Res.
37:3112018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chen Y, Xu H, Shi Q, Gu M, Wan X, Chen Q
and Wang Z: Hypoxia-inducible factor 1α (HIF-1α) mediates the
epithelial-mesenchymal transition in benign prostatic hyperplasia.
Int J Clin Exp Pathol. 12:295–304. 2019.PubMed/NCBI
|
|
94
|
Abouhashem NS, Ibrahim DA and Mohamed AM:
Prognostic implications of epithelial to mesenchymal transition
related proteins (E-cadherin, Snail) and hypoxia inducible factor
1α in endometrioid endometrial carcinoma. Ann Diagn Pathol.
22:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lee SY, Ju MK, Jeon HM, Lee YJ, Kim CH,
Park HG, Han SI and Kang HS: Oncogenic metabolism acts as a
prerequisite step for induction of cancer metastasis and cancer
stem cell phenotype. Oxid Med Cell Longev. 2018:10274532018.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Kouvaras E, Christoni Z, Siasios I,
Malizos K, Koukoulis GK and Ioannou M: Hypoxia-inducible factor
1-alpha and vascular endothelial growth factor in cartilage tumors.
Biotech Histochem. 94:283–289. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chabi S, Uzan B, Naguibneva I, Rucci J,
Fahy L, Calvo J, Arcangeli ML, Mazurier F, Pflumio F and Haddad R:
Hypoxia regulates lymphoid development of human hematopoietic
progenitors. Cell Rep. 29:2307–2320.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Barsoum IB, Smallwood CA, Siemens DR and
Graham CH: A mechanism of hypoxia-mediated escape from adaptive
immunity in cancer cells. Cancer Res. 74:665–674. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Polke M, Seiler F, Lepper PM, Kamyschnikow
A, Langer F, Monz D, Herr C, Bals R and Beisswenger C: Hypoxia and
the hypoxia-regulated transcription factor HIF-1α suppress the host
defence of airway epithelial cells. Innate Immun. 23:373–380. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Flück K, Breves G, Fandrey J and Winning
S: Hypoxia-inducible factor 1 in dendritic cells is crucial for the
activation of protective regulatory T cells in murine colitis.
Mucosal Immunol. 9:379–390. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Sun X, Kanwar JR, Leung E, Lehnert K, Wang
D and Krissansen GW: Gene transfer of antisense hypoxia inducible
factor-1 alpha enhances the therapeutic efficacy of cancer
immunotherapy. Gene Ther. 8:638–645. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Liu F, Wang P, Jiang X, Tan G, Qiao H,
Jiang H, Krissansen GW and Sun X: Antisense hypoxia-inducible
factor 1alpha gene therapy enhances the therapeutic efficacy of
doxorubicin to combat hepatocellular carcinoma. Cancer Sci.
99:2055–2061. 2008.PubMed/NCBI
|
|
103
|
Tartour E, Pere H, Maillere B, Terme M,
Merillon N, Taieb J, Sandoval F, Quintin-Colonna F, Lacerda K,
Karadimou A, et al: Angiogenesis and immunity: A bidirectional link
potentially relevant for the monitoring of antiangiogenic therapy
and the development of novel therapeutic combination with
immunotherapy. Cancer Metastasis Rev. 30:83–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wei J, Wu A, Kong LY, Wang Y, Fuller G,
Fokt I, Melillo G, Priebe W and Heimberger AB: Hypoxia potentiates
glioma-mediated immunosuppression. PLoS One. 6:e161952011.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wu A, Wei J, Kong LY, Wang Y, Priebe W,
Qiao W, Sawaya R and Heimberger AB: Glioma cancer stem cells induce
immunosuppressive macrophages/microglia. Neuro Oncol. 12:1113–1125.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Wei J, Barr J, Kong LY, Wang Y, Wu A,
Sharma AK, Gumin J, Henry V, Colman H, Priebe W, et al:
Glioblastoma cancer-initiating cells inhibit T-cell proliferation
and effector responses by the signal transducers and activators of
transcription 3 pathway. Mol Cancer Ther. 9:67–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Ye LY, Chen W, Bai XL, Xu XY, Zhang Q, Xia
XF, Sun X, Li GG, Hu QD, Fu QH, et al: Hypoxia-induced
epithelial-to-Mesenchymal transition in hepatocellular carcinoma
induces an immunosuppressive tumor microenvironment to promote
metastasis. Cancer Res. 76:818–830. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Noman MZ, Hasmim M, Messai Y, Terry S,
Kieda C, Janji B and Chouaib S: Hypoxia: A key player in antitumor
immune response. A review in the theme: Cellular responses to
hypoxia. Am J Physiol Cell Physiol. 309:C569–C579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Guo X, Xue H, Shao Q, Wang J, Guo X, Chen
X, Zhang J, Xu S, Li T, Zhang P, et al: Hypoxia promotes
glioma-associated macrophage infiltration via periostin and
subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Oncotarget. 7:80521–80542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Yu X, Li Z, Zhang Y, Xu M, Che Y, Tian X,
Wang R, Zou K and Zou L: β-elemene inhibits radiation and
hypoxia-induced macrophages infiltration via Prx-1/NF-κB/HIF-1α
signaling pathway. OncoTargets Ther. 12:4203–4211. 2019. View Article : Google Scholar
|
|
111
|
Cecil DL, Slota M, O'Meara MM, Curtis BC,
Gad E, Dang Y, Herendeen D, Rastetter L and Disis ML: Immunization
against HIF-1α inhibits the growth of basal mammary tumors and
targets mammary stem cells in vivo. Clin Cancer Res. 23:3396–3404.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
de Almeida PE, Mak J, Hernandez G,
Jesudason R, Herault A, Javinal V, Borneo J, Kim JM and Walsh KB:
Anti-VEGF treatment enhances CD8+ T-cell antitumor
activity by amplifying hypoxia. Cancer Immunol Res. 8:806–818.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Hasmim M, Noman MZ, Lauriol J, Benlalam H,
Mallavialle A, Rosselli F, Mami-Chouaib F, Alcaide-Loridan C and
Chouaib S: Hypoxia-dependent inhibition of tumor cell
susceptibility to CTL-mediated lysis involves NANOG induction in
target cells. J Immunol. 187:4031–4039. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Hasmim M, Noman MZ, Messai Y, Bordereaux
D, Gros G, Baud V and Chouaib S: Cutting edge: Hypoxia-induced
Nanog favors the intratumoral infiltration of regulatory T cells
and macrophages via direct regulation of TGF-β1. J Immunol.
191:5802–5806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Nam K, Oh S and Shin I: Ablation of CD44
induces glycolysis-to-oxidative phosphorylation transition via
modulation of the c-Src-Akt-LKB1-AMPKα pathway. Biochem J.
473:3013–3030. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Moldogazieva NT, Mokhosoev IM and
Terentiev AA: Metabolic heterogeneity of cancer cells: An interplay
between HIF-1, GLUTs, and AMPK. Cancers (Basel). 12:8622020.
View Article : Google Scholar
|
|
117
|
Semenza GL: Hypoxia-inducible factors:
Coupling glucose metabolism and redox regulation with induction of
the breast cancer stem cell phenotype. EMBO J. 36:252–259. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Kuo CY, Cheng CT, Hou P, Lin YP, Ma H,
Chung Y, Chi K, Chen Y, Li W, Kung HJ, et al: HIF-1-alpha links
mitochondrial perturbation to the dynamic acquisition of breast
cancer tumorigenicity. Oncotarget. 7:34052–34069. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Deshmukh A, Deshpande K, Arfuso F,
Newsholme P and Dharmarajan A: Cancer stem cell metabolism: A
potential target for cancer therapy. Mol Cancer. 15:692016.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Shen YA, Pan SC, Chu I, Lai RY and Wei YH:
Targeting cancer stem cells from a metabolic perspective. Exp Biol
Med (Maywood). 245:465–476. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Lai HT, Chiang CT, Tseng WK, Chao TC and
Su Y: GATA6 enhances the stemness of human colon cancer cells by
creating a metabolic symbiosis through upregulating LRH-1
expression. Mol Oncol. 14:1327–1347. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Song KH, Kim JH, Lee YH, Bae HC, Lee HJ,
Woo SR, Oh SJ, Lee KM, Yee C, Kim BW, et al: Mitochondrial
reprogramming via ATP5H loss promotes multimodal cancer therapy
resistance. J Clin Invest. 128:4098–4114. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Tang K, Yu Y, Zhu L, Xu P, Chen J, Ma J,
Zhang H, Fang H, Sun W, Zhou L, et al: Hypoxia-reprogrammed
tricarboxylic acid cycle promotes the growth of human breast
tumorigenic cells. Oncogene. 38:6970–6984. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Patra K, Jana S, Sarkar A, Mandal DP and
Bhattacharjee S: The inhibition of hypoxia-induced angiogenesis and
metastasis by cinnamaldehyde is mediated by decreasing HIF-1α
protein synthesis via PI3K/Akt pathway. Biofactors. 45:401–415.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Marhold M, Tomasich E, El-Gazzar A, Heller
G, Spittler A, Horvat R, Krainer M and Horak P: HIF1α regulates
mTOR signaling and viability of prostate cancer stem cells. Mol
Cancer Res. 13:556–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Jung J, Zhang Y, Celiku O, Zhang W, Song
H, Williams BJ, Giles AJ, Rich JN, Abounader R, Gilbert MR, et al:
Mitochondrial NIX promotes tumor survival in the hypoxic niche of
glioblastoma. Cancer Res. 79:5218–5232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Lv Z, Liu RD, Chen XQ, Wang B, Li LF, Guo
YS, Chen XJ and Ren XQ: HIF 1α promotes the stemness of oesophageal
squamous cell carcinoma by activating the Wnt/β catenin pathway.
Oncol Rep. 42:726–734. 2019.PubMed/NCBI
|
|
128
|
Xiang L, Gilkes DM, Hu H, Luo W, Bullen
JW, Liang H and Semenza GL: HIF-1α and TAZ serve as reciprocal
co-activators in human breast cancer cells. Oncotarget.
6:11768–11778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Zhang L, Shi H, Chen H, Gong A, Liu Y,
Song L, Xu X, You T, Fan X, Wang D, et al: Dedifferentiation
process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α
signaling enhances pancreatic cancer stemness. Cell Death Dis.
10:7242019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Qian J and Rankin EB: Hypoxia-induced
phenotypes that mediate tumor heterogeneity. Adv Exp Med Biol.
1136:43–55. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Luo M, Shang L, Brooks MD, Jiagge E, Zhu
Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, et al:
Targeting breast cancer stem cell state equilibrium through
modulation of redox signaling. Cell Metab. 28:69–86.e6. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Wang Y and Liu Y, Malek SN, Zheng P and
Liu Y: Targeting HIF1α eliminates cancer stem cells in
hematological malignancies. Cell Stem Cell. 8:399–411. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Hirata H, Yoshiura S, Ohtsuka T, Bessho Y,
Harada T, Yoshikawa K and Kageyama R: Oscillatory expression of the
bHLH factor Hes1 regulated by a negative feedback loop. Science.
298:840–843. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Almiron Bonnin DA, Havrda MC, Lee MC, Liu
H, Zhang Z, Nguyen LN, Harrington LX, Hassanpour S, Cheng C and
Israel MA: Secretion-mediated STAT3 activation promotes
self-renewal of glioma stem-like cells during hypoxia. Oncogene.
37:1107–1118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Zhang L, Huang G, Li X, Zhang Y, Jiang Y,
Shen J, Liu J, Wang Q, Zhu J, Feng X, et al: Hypoxia induces
epithelial-mesenchymal transition via activation of SNAI1 by
hypoxia-inducible factor −1α in hepatocellular carcinoma. BMC
Cancer. 13:1082013. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Yang SW, Zhang ZG, Hao YX, Zhao YL, Qian
F, Shi Y, Li PA, Liu CY and Yu PW: HIF-1α induces the
epithelial-mesenchymal transition in gastric cancer stem cells
through the Snail pathway. Oncotarget. 8:9535–9545. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J,
Sun T, Wang J, Sun R and Liu Y: Hypoxia promotes vasculogenic
mimicry formation by inducing epithelial-mesenchymal transition in
ovarian carcinoma. Gynecol Oncol. 133:575–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Lu H, Tran L, Park Y, Chen I, Lan J, Xie Y
and Semenza GL: Reciprocal regulation of DUSP9 and DUSP16
expression by HIF1 controls ERK and p38 MAP kinase activity and
mediates chemotherapy-induced breast cancer stem cell enrichment.
Cancer Res. 78:4191–4202. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Bhuria V, Xing J, Scholta T, Bui KC,
Nguyen MLT, Malek NP, Bozko P and Plentz RR: Hypoxia induced Sonic
Hedgehog signaling regulates cancer stemness,
epithelial-to-mesenchymal transition and invasion in
cholangiocarcinoma. Exp Cell Res. 385:1116712019. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Lv L, Yang Z, Ma T and Xuan Y: Gli1, a
potential cancer stem cell marker, is strongly associated with
prognosis in prostate cancer. Int J Clin Exp Pathol. 11:4957–4966.
2018.PubMed/NCBI
|
|
141
|
Qin J, Liu Y, Lu Y, Liu M, Li M, Li J and
Wu L: Hypoxia-inducible factor 1 alpha promotes cancer stem
cells-like properties in human ovarian cancer cells by upregulating
SIRT1 expression. Sci Rep. 7:105922017. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Guan Z, Ding C, Du Y, Zhang K, Zhu JN,
Zhang T, He D, Xu S, Wang X and Fan J: HAF drives the switch of
HIF-1α to HIF-2α by activating the NF-κB pathway, leading to
malignant behavior of T24 bladder cancer cells. Int J Oncol.
44:393–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Mendonça DB, Mendonça G, Aragão FJ and
Cooper LF: NF-κB suppresses HIF-1α response by competing for P300
binding. Biochem Biophys Res Commun. 404:997–1003. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Zhang Y, Jiang X, Qin X, Ye D, Yi Z, Liu
M, Bai O, Liu W, Xie X, Wang Z, et al: RKTG inhibits angiogenesis
by suppressing MAPK-mediated autocrine VEGF signaling and is
downregulated in clear-cell renal cell carcinoma. Oncogene.
29:5404–5415. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Roth U, Curth K, Unterman TG and Kietzmann
T: The transcription factors HIF-1 and HNF-4 and the coactivator
p300 are involved in insulin-regulated glucokinase gene expression
via the phosphatidylinositol 3-kinase/protein kinase B pathway. J
Biol Chem. 279:2623–2631. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Niu F, Li Y, Lai FF, Ni L, Ji M, Jin J,
Yang HZ, Wang C, Zhang DM and Chen XG: LB-1 exerts antitumor
activity in pancreatic cancer by inhibiting HIF-1α and Stat3
signaling. J Cell Physiol. 230:2212–2223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Kida A and Kahn M: Hypoxia selects for a
quiescent, CML stem/leukemia initiating-like population dependent
on CBP/catenin transcription. Curr Mol Pharmacol. 6:204–210. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Bordonaro M and Lazarova DL: CREB-binding
protein, p300, butyrate, and Wnt signaling in colorectal cancer.
World J Gastroenterol. 21:8238–8248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Yoon H, Lim JH, Cho CH, Huang LE and Park
JW: CITED2 controls the hypoxic signaling by snatching p300 from
the two distinct activation domains of HIF-1α. Biochim Biophys
Acta. 1813:2008–2016. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Jin P, Kang J, Lee MK and Park JW:
Ferritin heavy chain controls the HIF-driven hypoxic response by
activating the asparaginyl hydroxylase FIH. Biochem Biophys Res
Commun. 499:475–481. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Lee GY, Shin SH, Shin HW, Chun YS and Park
JW: NDRG3 lowers the metastatic potential in prostate cancer as a
feedback controller of hypoxia-inducible factors. Exp Mol Med.
50:1–13. 2018. View Article : Google Scholar
|
|
152
|
Papale M, Buccarelli M, Mollinari C, Russo
MA, Pallini R, Ricci-Vitiani L and Tafani M: Hypoxia, inflammation
and necrosis as determinants of glioblastoma cancer stem cells
progression. Int J Mol Sci. 21:26602020. View Article : Google Scholar
|
|
153
|
Kessler J, Hahnel A, Wichmann H, Rot S,
Kappler M, Bache M and Vordermark D: HIF-1α inhibition by siRNA or
chetomin in human malignant glioma cells: Effects on hypoxic
radioresistance and monitoring via CA9 expression. BMC Cancer.
10:6052010. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Lo WL, Chien Y, Chiou GY, Tseng LM, Hsu
HS, Chang YL, Lu KH, Chien CS, Wang ML, Chen YW, et al: Nuclear
localization signal-enhanced RNA interference of EZH2 and Oct4 in
the eradication of head and neck squamous cell carcinoma-derived
cancer stem cells. Biomaterials. 33:3693–3709. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Li SH, Shin DH, Chun YS, Lee MK, Kim MS
and Park JW: A novel mode of action of YC-1 in HIF inhibition:
Stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}.
Mol Cancer Ther. 7:3729–3738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Shin DH, Chun YS, Lee DS, Huang LE and
Park JW: Bortezomib inhibits tumor adaptation to hypoxia by
stimulating the FIH-mediated repression of hypoxia-inducible
factor-1. Blood. 111:3131–3136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Yang C, Wang W, Li GD, Zhong HJ, Dong ZZ,
Wong CY, Kwong DW, Ma DL and Leung CH: Anticancer osmium complex
inhibitors of the HIF-1α and p300 protein-protein interaction. Sci
Rep. 7:428602017. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Fernandez EV, Reece KM, Ley AM, Troutman
SM, Sissung TM, Price DK, Chau CH and Figg WD: Dual targeting of
the androgen receptor and hypoxia-inducible factor 1α pathways
synergistically inhibits castration-resistant prostate cancer
cells. Mol Pharmacol. 87:1006–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Goradel NH, Asghari MH, Moloudizargari M,
Negahdari B, Haghi-Aminjan H and Abdollahi M: Melatonin as an
angiogenesis inhibitor to combat cancer: Mechanistic evidence.
Toxicol Appl Pharmacol. 335:56–63. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Harris EM, Strope JD, Beedie SL, Huang PA,
Goey AK, Cook KM, Schofield CJ, Chau CH, Cadelis MM, Copp BR, et
al: Preclinical evaluation of discorhabdins in antiangiogenic and
antitumor models. Mar Drugs. 16:2412018. View Article : Google Scholar
|
|
161
|
Chen H, Guan Y, Yuan G, Zhang Q and Jing
N: A perylene derivative regulates HIF-1α and Stat3 signaling
pathways. Bioorg Med Chem. 22:1496–1505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
McGinn O, Gupta VK, Dauer P, Arora N,
Sharma N, Nomura A, Dudeja V, Saluja A and Banerjee S: Inhibition
of hypoxic response decreases stemness and reduces tumorigenic
signaling due to impaired assembly of HIF1 transcription complex in
pancreatic cancer. Sci Rep. 7:78722017. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Wang T, Shigdar S, Gantier MP, Hou Y, Wang
L, Li Y, Shamaileh HA, Yin W, Zhou SF, Zhao X, et al: Cancer stem
cell targeted therapy: Progress amid controversies. Oncotarget.
6:44191–44206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Xiang L and Semenza GL: Hypoxia-inducible
factors promote breast cancer stem cell specification and
maintenance in response to hypoxia or cytotoxic chemotherapy. Adv
Cancer Res. 141:175–212. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Yeo CD, Kang N, Choi SY, Kim BN, Park CK,
Kim JW, Kim YK and Kim SJ: The role of hypoxia on the acquisition
of epithelial-mesenchymal transition and cancer stemness: A
possible link to epigenetic regulation. Korean J Intern Med.
32:589–599. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Lee JH, Hur W, Hong SW, Kim JH, Kim SM,
Lee EB and Yoon SK: ELK3 promotes the migration and invasion of
liver cancer stem cells by targeting HIF-1α. Oncol Rep. 37:813–822.
2017. View Article : Google Scholar : PubMed/NCBI
|
